In particular, high methylation of CpG sites in exon I and low serum levels of BDNF were associated with MDD (D'Addario et al., 2013; Carlberg et al., 2014) and depression in patients characterized by bipolar II disorders (Dell'Osso et al., 2014). The gene discussed is BDNF; the disease is bipolar II disorder.